Last reviewed · How we verify
Docetaxel: increase of the dose
Docetaxel: increase of the dose is a Small molecule drug developed by Centre Oscar Lambret. It is currently in Phase 2 development. Also known as: Taxotere.
At a glance
| Generic name | Docetaxel: increase of the dose |
|---|---|
| Also known as | Taxotere |
| Sponsor | Centre Oscar Lambret |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer (PHASE2)
- A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors (PHASE1, PHASE2)
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors (PHASE2)
- ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer (PHASE3)
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D (PHASE3)
- A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors. (PHASE1)
- A Dose-finding Trial of Hyperthermic Intraperitoneal Docetaxel (PHASE1)
- Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Docetaxel: increase of the dose CI brief — competitive landscape report
- Docetaxel: increase of the dose updates RSS · CI watch RSS
- Centre Oscar Lambret portfolio CI
Frequently asked questions about Docetaxel: increase of the dose
What is Docetaxel: increase of the dose?
Docetaxel: increase of the dose is a Small molecule drug developed by Centre Oscar Lambret.
Who makes Docetaxel: increase of the dose?
Docetaxel: increase of the dose is developed by Centre Oscar Lambret (see full Centre Oscar Lambret pipeline at /company/centre-oscar-lambret).
Is Docetaxel: increase of the dose also known as anything else?
Docetaxel: increase of the dose is also known as Taxotere.
What development phase is Docetaxel: increase of the dose in?
Docetaxel: increase of the dose is in Phase 2.
Related
- Manufacturer: Centre Oscar Lambret — full pipeline
- Also known as: Taxotere
- Compare: Docetaxel: increase of the dose vs similar drugs
- Pricing: Docetaxel: increase of the dose cost, discount & access